A Providence study released online today in the Journal of the American Medical Association sheds new light on the added benefit of a booster dose of a COVID-19 mRNA vaccine among previously vaccinated individuals.
Researchers from Northern Arizona University and the University of Washington School of Medicine in collaboration with the Washington National Primate Research Center received a five-year, $7.5 million grant from the National Institutes of Health to fund a groundbreaking project that they hope will result in a safe and effective vaccine for Valley Fever.
A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis details clarified expert consensus to help guide providers on latest data and information, available at NCCN.org/covid-19.
LJI research shows that a "slow delivery, escalating dose" vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
Jasmin A. Tiro, PhD, MPH, has joined the University of Chicago Medicine Comprehensive Cancer Center as the new Associate Director of Cancer Prevention and Population Sciences. Tiro was formerly Professor of Population and Data Sciences at Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center in Dallas.
20240326113011.png&width=400&height=400){kind=logo}
Though well-known as a respiratory illness, COVID-19 can also affect the nervous system. Now, researchers reporting in ACS Infectious Diseases have developed a new tool and possible vaccine candidate that could help scientists understand how SARS-CoV-2 could be invading these cells.
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.
Acinetobacter baumannii is a bacterial pathogen responsible for serious hospital-related infections that is becoming increasingly resistant against antibiotics.
A Rutgers infectious disease expert explains why getting the annual flu shot is important to individual and public health
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Both an advisory from the American College of Obstetricians and Gynecologists and a new study encourage pregnant or lactating individuals to receive the latest COVID booster.
Sarah Knight, MD, Primary Care, Internal Medicine at Ochsner Health shares tips for staying healthy this flu season.
Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. The paper, which published today in The Lancet Global Health, explores the feasibility of eliminating measles and rubella using predominant vaccination strategies in 93 countries with the highest disease burden.
The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers. The new yearlong grant project follows the 2020–21 Preventing Emerging Infections Through Vaccine Effectiveness Testing study, or PREVENT I, which was among the first to demonstrate the real-world benefit of mRNA vaccines in preventing symptomatic infection following their authorization by the Food and Drug Administration.
A new study uses a data-intelligent model to highlight the need to boost vaccination campaign budgets for disadvantaged, vulnerable populations to reach the maximum health benefit for everyone.
Key steps that everyone involved in pre-K - 12th grade schools can take to reduce the risk that COVID-19 will disrupt yet another school year.
Covid-19 vaccine companies influence each other's stock prices as well as market volatility, a team of scientists has found.
Despite recent claims on social media, the UK government has not changed its position on pregnant or breastfeeding women getting the COVID booster. The NHS says the vaccine is both safe and strongly recommended for this group.
To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses. In a step toward achieving that goal, one potential vaccine component has led to strong protection in primates by eliciting an antibody that binds to part of the virus’s outer envelope, reports a team led by researchers at the Duke Human Vaccine Institute (DHVI).
In the first year of its availability, 84.2% of US adults received at least one dose of COVID-19 vaccine.
A published study of 1,899 pregnant women nationwide representing all 50 states reveals that during the Covid-19 pandemic if a pregnant woman had lower socioeconomic status and/or were African American, she was less likely to have the intention of taking a Covid-19 vaccine or actually receiving it.
The latest research and expert commentary on pain management.
Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.
Arizona State University rose three spots to No. 8 for U.S. utility patents issued to universities worldwide in 2021, continuing to help drive American technological evolution and success. This marks the second time that ASU ranked in the top 10 among universities worldwide and the fourth time that ASU ranked in the top 10 among U.S.-based universities in the annual ranking by the National Academy of Inventors and the Intellectual Property Owners Association.
Being vaccinated with at least two doses of Pfizer vaccines dramatically reduces most of the long-term symptoms individuals reported months after contracting COVID-19, a new study shows.
Neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults tend to decline by at least 15% per month after a single booster shot, a new study using serum from human blood samples suggests.
Getting an annual flu shot may be associated with a lower risk of stroke, according to a study published in the September 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Analysis across 67 countries highlights how among those who believe in COVID-19 conspiracy theories, a strong sense of morality increases support for COVID-19 prevention behaviors.
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association’s flagship journal Circulation.
Researchers analyzed how the expectation of a vaccine influences optimal lockdown measures during a pandemic.
SEATTLE — Sept. 1, 2022 — Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.Please note: On April 1, Fred Hutchinson Cancer Research Center merged with our care partner, Seattle Cancer Care Alliance. Our new name is Fred Hutchinson Cancer Center (Fred Hutch on subsequent references).
Two vaccine doses provide only limited and short-lived protection against SARS-CoV-2 infection with the Omicron variant. A study publishing September 1st in the open-access journal PLOS Medicine by Mie Agermose Gram at Statens Serum Institut, Copenhagen, Denmark, and colleagues suggests that a third COVID-19 vaccine dose increased the level and duration of protection against Omicron infection and hospitalization.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
The latest research on plants brought to you by Newswise.
Adding an ingredient called an adjuvant can help vaccines elicit a more robust immune response. In a study in ACS Infectious Diseases, researchers report a substance that boosted the immune response to an experimental COVID-19 shot in mice by 25 times, compared to injection with the vaccine alone.
The human papillomavirus (HPV) vaccine is safe and effective – but it’s not for everyone. Michelle Ozbun, PhD, and her team at UNM Cancer Center published a research article earlier this year in Antimicrobial Agents and Chemotherapy in which they describe how a drug called protamine sulfate blocks HPV infection. Like a game of musical chairs among molecules, the drug molecules bind to heparan sulfate cell receptors, preventing HPV virus particles from doing so.
A recent case of polio in the U.S. sounds the alarm for more vaccination.
The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with cash incentives and if it is made by Moderna or Pfizer.
Infectious Disease experts at Ochsner Health in New Orleans reveal the top 10 myths about the flu and flu vaccines in 2022.
When the Biden administration announced COVID-19 vaccine mandates on Nov. 4 for businesses with 100 or more employees, protests erupted in cities across the U.S.
Monkeypox cases are on the rise in the U.S., stoking fear and confusion about the way the virus is spread, who is at risk and where to seek treatment.
A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
The remarkable effectiveness of mRNA vaccines against SARS-CoV-2 has generated much interest in synthetic mRNA therapeutics for treating and preventing disease. But some basic science questions have remained about whether the modified nucleotides used in the vaccines faithfully produce the protein products that they are designed to make.
New research from the Department of Psychological & Brain Sciences in Arts & Sciences indicates that fear-based messaging may result in mixed effects when it comes to public health.
Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the peer-reviewed journal Neurology, will ease the minds of individuals still hesitant to be vaccinated.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
